sBCMA could be detected in supernatants of CLL cells, (Fig. 2F), which strongly decreased upon treatment with γ-secretase inhibitor, compatible with decreased BCMA shedding by the CLL cells (Fig. 2F). This evidence concerns the gene TNFRSF17 and B-cell chronic lymphocytic leukemia.